Anti-cancer Therapies Employing IL-2 Cytokine Tumor Targeting: Contribution of Innate, Adaptive and Immunosuppressive Cells in the Anti-tumor Efficacy

Lignende værker

• Schedule-dependent therapeutic efficacy of L19mTNF-α and melphalan combined with gemcitabine
  af: Mortara, Lorenzo, et al.
  Udgivet: (2013)
• Contribution to Tumor Angiogenesis From Innate Immune Cells Within the Tumor Microenvironment: Implications for Immunotherapy
  af: Albini, Adriana, et al.
  Udgivet: (2018)
• Natural Killer Cells as Key Players of Tumor Progression and Angiogenesis: Old and Novel Tools to Divert Their Pro-Tumor Activities into Potent Anti-Tumor Effects
  af: Bassani, Barbara, et al.
  Udgivet: (2019)
• L19-IL2 Immunocytokine in Combination with the Anti-Syndecan-1 46F2SIP Antibody Format: A New Targeted Treatment Approach in an Ovarian Carcinoma Model
  af: Orecchia, Paola, et al.
  Udgivet: (2019)
• Targeting Syndecan-1, a molecule implicated in the process of vasculogenic mimicry, enhances the therapeutic efficacy of the L19-IL2 immunocytokine in human melanoma xenografts
  af: Orecchia, Paola, et al.
  Udgivet: (2015)